Market Taxonomy:
On the basis of distribution channel, the global urokinase market is segmented into:
On the basis of Formulation, the global urokinase market is segmented into:
On the basis of region, the global urokinase market is segmented into:
Global Urokinase Market Restraints
Urokinase is contraindicated in cancer patients, as urokinase elevates plasminogen activation systems, which causes tissue invasion leading towards metastasis and causing cancer growth. Moreover, urokinase is also contraindicated in patients suffering from brain tumor and high blood pressure. These factors are expected to restrain growth of the global urokinase market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients